                         SEQUENCE LISTING

<110>  APTAMIR THERAPEUTICS, INC.
 
<120>  INHIBITION OF MIR-22 MIRNA BY APT-110

<130>  APTA.P0007WO

<140>  UNKNOWN
<141>  2017-04-28

<150>  62/329,537
<151>  2016-04-29

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  1

Gly Val Ile Thr Arg Ile Arg 
1               5           


<210>  2
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  2

His Trp Ala Trp Phe Leu 
1               5       


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Peptide

<400>  3

Cys Lys Gly Gly Arg Ala Lys Asp Cys 
1               5                   


<210>  4
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Primer


<220>
<221>  misc_feature
<222>  (1)..(18)
<223>  All internucleotide linkages are phosphorothioates

<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Locked nucleic acid

<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Locked nucleic acid

<220>
<221>  misc_feature
<222>  (4)..(4)
<223>  2' OCH3 substitution and not methylated at the 5 position

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Locked nucleic acid

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  5-methyl substitution

<220>
<221>  misc_feature
<222>  (10)..(10)
<223>  2' OCH3 substitution and not methylated at the 5 position

<220>
<221>  misc_feature
<222>  (12)..(12)
<223>  Locked nucleic acid

<220>
<221>  misc_feature
<222>  (14)..(14)
<223>  Locked nucleic acid

<220>
<221>  misc_feature
<222>  (14)..(14)
<223>  5-methyl substitution

<220>
<221>  misc_feature
<222>  (15)..(15)
<223>  Locked nucleic acid

<220>
<221>  misc_feature
<222>  (17)..(17)
<223>  Locked nucleic acid

<220>
<221>  misc_feature
<222>  (17)..(17)
<223>  5-methyl substitution

<220>
<221>  misc_feature
<222>  (18)..(18)
<223>  Locked nucleic acid

<400>  4
cttcttcaac tggcagct                                                     18


<210>  5
<211>  23
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Primer

<400>  5
uggaaaugaa uuacaggcag cug                                               23


<210>  6
<211>  22
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Primer

<400>  6
aagcugccag uugaagaacu gu                                                22


<210>  7
<211>  23
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Primer

<400>  7
cccuuccacc ccauuggcag cuc                                               23


<210>  8
<211>  22
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Primer

<400>  8
aagcugccag uugaagaacu gu                                                22


<210>  9
<211>  23
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Primer

<400>  9
cuccgggccc cauuuggcag cuc                                               23


<210>  10
<211>  22
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Primer

<400>  10
aagcugccag uugaagaacu gu                                                22


<210>  11
<211>  84
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Primer


<220>
<221>  misc_feature
<222>  (62)..(62)
<223>  n is a, c, g, or u

<220>
<221>  misc_feature
<222>  (72)..(73)
<223>  n is a, c, g, or u

<400>  11
ggcugagccg caguaguucu ucaguggcaa gcuuuauguc cugacccagc uaaagcugcc       60

ancugaagaa cnnugcccuc ugcc                                              84


